View Author
carcinoma tumor treatment patient temozolomide endocrinol shrinkage range report prl-secreting carcinoma scheithauer cycle tmz treatment review intradural metastasis metastase expression metastasi hormone administration acth-secreting mgmt expression temozolomide-induced tmz administration kovac macroadenoma literature cushing adenomas cancer cortisol surgery 2132–2138 therapy month tumor volume adenoma case report ki -67 antigen corticotroph ki -67 index management 5 days tmz cycles acth-secreting carcinoma disease evaluation growth 150 mg /m approach intradural transformation neoplasm methyltransferase prl-secreting metab volume table study imaging condition guanine residues tumor shrinkage effect 6-methylguanine department -67 6-methylguanine methyltransferase foramen magnum novel treatment dopamine agonists temozolomide therapy hormone secretion gd-dtpa administration subtotal resection dexamethasone change tumor remnant grade 4 17 months
1 Most Recent Publications
|
Temozolomide-induced shrinkage of a pituitary carcinoma causing cushing's disease - Report of a case and literature review
(Article)
Curtò, L. Torre, M.L. Ferrau, F. Pitini, V. Altavilla, G. Granata, F. Longo, M. Hofland, L.J. Trimarchi, F. Cannavò, S. |
2010-11-04
|